Structure

Physi-Chem Properties

Molecular Weight:  516.13
Volume:  491.768
LogP:  1.75
LogD:  0.578
LogS:  -1.871
# Rotatable Bonds:  9
TPSA:  211.28
# H-Bond Aceptor:  12
# H-Bond Donor:  7
# Rings:  3
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.156
Synthetic Accessibility Score:  4.141
Fsp3:  0.24
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.441
MDCK Permeability:  6.999346624070313e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.658
Human Intestinal Absorption (HIA):  0.801
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.054
Plasma Protein Binding (PPB):  98.28722381591797%
Volume Distribution (VD):  0.306
Pgp-substrate:  1.6515036821365356%

ADMET: Metabolism

CYP1A2-inhibitor:  0.471
CYP1A2-substrate:  0.013
CYP2C19-inhibitor:  0.109
CYP2C19-substrate:  0.039
CYP2C9-inhibitor:  0.566
CYP2C9-substrate:  0.51
CYP2D6-inhibitor:  0.088
CYP2D6-substrate:  0.151
CYP3A4-inhibitor:  0.072
CYP3A4-substrate:  0.055

ADMET: Excretion

Clearance (CL):  3.051
Half-life (T1/2):  0.924

ADMET: Toxicity

hERG Blockers:  0.122
Human Hepatotoxicity (H-HT):  0.45
Drug-inuced Liver Injury (DILI):  0.526
AMES Toxicity:  0.062
Rat Oral Acute Toxicity:  0.125
Maximum Recommended Daily Dose:  0.092
Skin Sensitization:  0.95
Carcinogencity:  0.129
Eye Corrosion:  0.003
Eye Irritation:  0.138
Respiratory Toxicity:  0.028

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC35702

Natural Product ID:  NPC35702
Common Name*:   UFCLZKMFXSILNL-JFZVQIRRSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  UFCLZKMFXSILNL-JFZVQIRRSA-N
Standard InCHI:  InChI=1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(31)36-20-12-25(35,24(33)34)11-19(30)23(20)37-22(32)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-30,35H,11-12H2,(H,33,34)/b7-3+,8-4+/t19-,20-,23-,25-/m1/s1
SMILES:  c1cc(c(cc1/C=C/C(=O)O[C@@H]1C[C@](C[C@H]([C@H]1OC(=O)/C=C/c1ccc(c(c1)O)O)O)(C(=O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3325469
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000129] Alcohols and polyols
          • [CHEMONTID:0001292] Cyclic alcohols and derivatives
            • [CHEMONTID:0002509] Cyclitols and derivatives
              • [CHEMONTID:0002512] Quinic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12728 Artemisia rupestris Species Asteraceae Eukaryota Whole plant n.a. n.a. PMID[25127164]
NPO12728 Artemisia rupestris Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[25176187]
NPO12728 Artemisia rupestris Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[26696523]
NPO40047 Blumea aromatica Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[31646857]
NPO12728 Artemisia rupestris Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO12728 Artemisia rupestris Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO12728 Artemisia rupestris Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO12728 Artemisia rupestris Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 20170.0 nM PMID[449633]
NPT113 Cell Line RAW264.7 Mus musculus Inhibition = 15.5 % PMID[449634]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC35702 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC477335
1.0 High Similarity NPC471027
1.0 High Similarity NPC297517
1.0 High Similarity NPC224389
1.0 High Similarity NPC13818
1.0 High Similarity NPC206095
0.9926 High Similarity NPC258469
0.9926 High Similarity NPC284948
0.9926 High Similarity NPC43158
0.9926 High Similarity NPC277315
0.9926 High Similarity NPC37331
0.9926 High Similarity NPC220664
0.9926 High Similarity NPC303090
0.9926 High Similarity NPC319628
0.9926 High Similarity NPC192831
0.9926 High Similarity NPC472016
0.9776 High Similarity NPC302857
0.9776 High Similarity NPC37250
0.9776 High Similarity NPC142703
0.9776 High Similarity NPC278068
0.9776 High Similarity NPC152942
0.9776 High Similarity NPC219428
0.9704 High Similarity NPC26241
0.9704 High Similarity NPC295492
0.9704 High Similarity NPC474875
0.9704 High Similarity NPC476820
0.9704 High Similarity NPC205751
0.9704 High Similarity NPC274891
0.9704 High Similarity NPC303683
0.9704 High Similarity NPC476819
0.9638 High Similarity NPC477333
0.963 High Similarity NPC24295
0.963 High Similarity NPC283560
0.9571 High Similarity NPC192568
0.9571 High Similarity NPC471076
0.9504 High Similarity NPC42464
0.95 High Similarity NPC322660
0.9478 High Similarity NPC68517
0.9437 High Similarity NPC306343
0.9433 High Similarity NPC43123
0.9407 High Similarity NPC233350
0.9407 High Similarity NPC182217
0.9407 High Similarity NPC70680
0.9306 High Similarity NPC163883
0.9306 High Similarity NPC93498
0.9291 High Similarity NPC98356
0.9241 High Similarity NPC19380
0.9241 High Similarity NPC146277
0.9236 High Similarity NPC477334
0.9149 High Similarity NPC50221
0.9149 High Similarity NPC114242
0.9116 High Similarity NPC145425
0.9103 High Similarity NPC252979
0.9054 High Similarity NPC473275
0.9054 High Similarity NPC470896
0.9044 High Similarity NPC25581
0.9044 High Similarity NPC18074
0.9044 High Similarity NPC5419
0.9044 High Similarity NPC61
0.9014 High Similarity NPC22176
0.9014 High Similarity NPC121573
0.9014 High Similarity NPC226738
0.9014 High Similarity NPC190587
0.9 High Similarity NPC179505
0.9 High Similarity NPC156709
0.8978 High Similarity NPC168799
0.8978 High Similarity NPC155209
0.8971 High Similarity NPC198388
0.8958 High Similarity NPC229264
0.8913 High Similarity NPC474895
0.8897 High Similarity NPC142528
0.8857 High Similarity NPC67349
0.8857 High Similarity NPC279676
0.8803 High Similarity NPC38473
0.88 High Similarity NPC134925
0.8777 High Similarity NPC106406
0.8767 High Similarity NPC120621
0.8767 High Similarity NPC248257
0.8741 High Similarity NPC477277
0.8741 High Similarity NPC477278
0.8733 High Similarity NPC203757
0.8732 High Similarity NPC12218
0.8732 High Similarity NPC75763
0.8732 High Similarity NPC105525
0.8732 High Similarity NPC225036
0.8725 High Similarity NPC44730
0.8716 High Similarity NPC140151
0.8707 High Similarity NPC92117
0.8707 High Similarity NPC75945
0.8705 High Similarity NPC471749
0.8701 High Similarity NPC227297
0.8696 High Similarity NPC318799
0.8671 High Similarity NPC477279
0.8662 High Similarity NPC239943
0.8639 High Similarity NPC472969
0.863 High Similarity NPC473867
0.8623 High Similarity NPC237506
0.8623 High Similarity NPC32626
0.8623 High Similarity NPC217052
0.8623 High Similarity NPC329344
0.8621 High Similarity NPC474692
0.8621 High Similarity NPC160378
0.8603 High Similarity NPC475695
0.8601 High Similarity NPC289690
0.8601 High Similarity NPC288452
0.86 High Similarity NPC44260
0.86 High Similarity NPC205037
0.86 High Similarity NPC16024
0.86 High Similarity NPC61152
0.86 High Similarity NPC3746
0.8592 High Similarity NPC302583
0.8592 High Similarity NPC84789
0.8592 High Similarity NPC310252
0.8592 High Similarity NPC100558
0.859 High Similarity NPC471823
0.8581 High Similarity NPC98809
0.8581 High Similarity NPC476394
0.8571 High Similarity NPC283081
0.8571 High Similarity NPC221383
0.8571 High Similarity NPC143892
0.8571 High Similarity NPC299090
0.8551 High Similarity NPC94810
0.8542 High Similarity NPC9218
0.8535 High Similarity NPC128403
0.8533 High Similarity NPC95498
0.8533 High Similarity NPC106818
0.8533 High Similarity NPC75695
0.8533 High Similarity NPC246566
0.8523 High Similarity NPC259576
0.8523 High Similarity NPC221091
0.8523 High Similarity NPC32197
0.8511 High Similarity NPC886
0.8511 High Similarity NPC287597
0.8511 High Similarity NPC34293
0.8511 High Similarity NPC248150
0.8493 Intermediate Similarity NPC229036
0.8493 Intermediate Similarity NPC470130
0.8477 Intermediate Similarity NPC87403
0.8467 Intermediate Similarity NPC243891
0.8467 Intermediate Similarity NPC300329
0.8456 Intermediate Similarity NPC85565
0.8451 Intermediate Similarity NPC123988
0.8451 Intermediate Similarity NPC18646
0.8442 Intermediate Similarity NPC287872
0.8442 Intermediate Similarity NPC74319
0.8435 Intermediate Similarity NPC108455
0.8435 Intermediate Similarity NPC258671
0.8435 Intermediate Similarity NPC53884
0.8431 Intermediate Similarity NPC239019
0.8431 Intermediate Similarity NPC247629
0.8429 Intermediate Similarity NPC108553
0.8421 Intermediate Similarity NPC191046
0.8421 Intermediate Similarity NPC327032
0.8421 Intermediate Similarity NPC194095
0.8417 Intermediate Similarity NPC226855
0.8411 Intermediate Similarity NPC476434
0.8411 Intermediate Similarity NPC267091
0.8403 Intermediate Similarity NPC328273
0.8403 Intermediate Similarity NPC321638
0.8403 Intermediate Similarity NPC321184
0.8403 Intermediate Similarity NPC171134
0.84 Intermediate Similarity NPC473091
0.8397 Intermediate Similarity NPC90905
0.8397 Intermediate Similarity NPC4013
0.8392 Intermediate Similarity NPC156892
0.8389 Intermediate Similarity NPC98009
0.8389 Intermediate Similarity NPC28776
0.8389 Intermediate Similarity NPC473138
0.8387 Intermediate Similarity NPC289346
0.8387 Intermediate Similarity NPC24164
0.838 Intermediate Similarity NPC135127
0.8378 Intermediate Similarity NPC474465
0.8377 Intermediate Similarity NPC114179
0.8377 Intermediate Similarity NPC160512
0.8377 Intermediate Similarity NPC172419
0.8377 Intermediate Similarity NPC289322
0.8377 Intermediate Similarity NPC156818
0.8377 Intermediate Similarity NPC472860
0.8377 Intermediate Similarity NPC226759
0.8377 Intermediate Similarity NPC38779
0.8377 Intermediate Similarity NPC238419
0.8377 Intermediate Similarity NPC133984
0.8377 Intermediate Similarity NPC68324
0.837 Intermediate Similarity NPC472271
0.837 Intermediate Similarity NPC147654
0.8367 Intermediate Similarity NPC473090
0.8367 Intermediate Similarity NPC183824
0.8367 Intermediate Similarity NPC304956
0.8355 Intermediate Similarity NPC266084
0.8355 Intermediate Similarity NPC473544
0.8355 Intermediate Similarity NPC475145
0.8355 Intermediate Similarity NPC475216
0.8355 Intermediate Similarity NPC83663
0.8355 Intermediate Similarity NPC475595
0.8355 Intermediate Similarity NPC475162
0.8333 Intermediate Similarity NPC472859
0.8333 Intermediate Similarity NPC25389
0.8333 Intermediate Similarity NPC78363
0.8333 Intermediate Similarity NPC478242
0.8333 Intermediate Similarity NPC260425

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC35702 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9926 High Similarity NPD6190 Approved
0.8312 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.831 Intermediate Similarity NPD230 Phase 1
0.8276 Intermediate Similarity NPD7266 Discontinued
0.8037 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD6166 Phase 2
0.784 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7786 Intermediate Similarity NPD9269 Phase 2
0.7785 Intermediate Similarity NPD3817 Phase 2
0.7771 Intermediate Similarity NPD7685 Pre-registration
0.7744 Intermediate Similarity NPD3818 Discontinued
0.7736 Intermediate Similarity NPD3882 Suspended
0.7722 Intermediate Similarity NPD2801 Approved
0.7712 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD5402 Approved
0.7671 Intermediate Similarity NPD6233 Phase 2
0.7658 Intermediate Similarity NPD1934 Approved
0.764 Intermediate Similarity NPD6234 Discontinued
0.7632 Intermediate Similarity NPD8166 Discontinued
0.7632 Intermediate Similarity NPD4628 Phase 3
0.7628 Intermediate Similarity NPD1653 Approved
0.7613 Intermediate Similarity NPD1512 Approved
0.761 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD6797 Phase 2
0.7603 Intermediate Similarity NPD3764 Approved
0.759 Intermediate Similarity NPD5844 Phase 1
0.7578 Intermediate Similarity NPD7075 Discontinued
0.756 Intermediate Similarity NPD7251 Discontinued
0.7554 Intermediate Similarity NPD9545 Approved
0.7547 Intermediate Similarity NPD37 Approved
0.7534 Intermediate Similarity NPD3027 Phase 3
0.7532 Intermediate Similarity NPD4380 Phase 2
0.753 Intermediate Similarity NPD3751 Discontinued
0.7516 Intermediate Similarity NPD4966 Approved
0.7516 Intermediate Similarity NPD4967 Phase 2
0.7516 Intermediate Similarity NPD4965 Approved
0.75 Intermediate Similarity NPD6232 Discontinued
0.75 Intermediate Similarity NPD943 Approved
0.75 Intermediate Similarity NPD9268 Approved
0.75 Intermediate Similarity NPD1465 Phase 2
0.7485 Intermediate Similarity NPD7054 Approved
0.7484 Intermediate Similarity NPD1511 Approved
0.7483 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD8150 Discontinued
0.744 Intermediate Similarity NPD7074 Phase 3
0.744 Intermediate Similarity NPD7472 Approved
0.7438 Intermediate Similarity NPD6801 Discontinued
0.7425 Intermediate Similarity NPD7228 Approved
0.7412 Intermediate Similarity NPD7808 Phase 3
0.7397 Intermediate Similarity NPD9494 Approved
0.7394 Intermediate Similarity NPD3787 Discontinued
0.7391 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD1613 Approved
0.7372 Intermediate Similarity NPD6799 Approved
0.7371 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD6798 Discontinued
0.7365 Intermediate Similarity NPD7473 Discontinued
0.7362 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD3455 Phase 2
0.7349 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD5403 Approved
0.7333 Intermediate Similarity NPD7199 Phase 2
0.7303 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD8434 Phase 2
0.7226 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD5401 Approved
0.7181 Intermediate Similarity NPD7095 Approved
0.716 Intermediate Similarity NPD6386 Approved
0.716 Intermediate Similarity NPD6385 Approved
0.7143 Intermediate Similarity NPD2935 Discontinued
0.7126 Intermediate Similarity NPD8127 Discontinued
0.7114 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD6355 Discontinued
0.7099 Intermediate Similarity NPD6599 Discontinued
0.7086 Intermediate Similarity NPD4062 Phase 3
0.7078 Intermediate Similarity NPD1510 Phase 2
0.7078 Intermediate Similarity NPD7033 Discontinued
0.7076 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD7819 Suspended
0.7066 Intermediate Similarity NPD5494 Approved
0.7055 Intermediate Similarity NPD7411 Suspended
0.7051 Intermediate Similarity NPD1549 Phase 2
0.7047 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD9570 Approved
0.703 Intermediate Similarity NPD5353 Approved
0.7007 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6535 Approved
0.7 Intermediate Similarity NPD6534 Approved
0.6993 Remote Similarity NPD4340 Discontinued
0.6993 Remote Similarity NPD447 Suspended
0.6993 Remote Similarity NPD5536 Phase 2
0.6987 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6987 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6973 Remote Similarity NPD7435 Discontinued
0.697 Remote Similarity NPD8455 Phase 2
0.6962 Remote Similarity NPD3750 Approved
0.6954 Remote Similarity NPD7039 Approved
0.6954 Remote Similarity NPD6559 Discontinued
0.6954 Remote Similarity NPD7240 Approved
0.6954 Remote Similarity NPD7038 Approved
0.6943 Remote Similarity NPD970 Clinical (unspecified phase)
0.6941 Remote Similarity NPD5242 Approved
0.6939 Remote Similarity NPD1608 Approved
0.6928 Remote Similarity NPD826 Approved
0.6928 Remote Similarity NPD825 Approved
0.6928 Remote Similarity NPD4060 Phase 1
0.6923 Remote Similarity NPD1551 Phase 2
0.6906 Remote Similarity NPD3022 Approved
0.6906 Remote Similarity NPD3021 Approved
0.6902 Remote Similarity NPD6781 Approved
0.6902 Remote Similarity NPD6778 Approved
0.6902 Remote Similarity NPD6782 Approved
0.6902 Remote Similarity NPD6780 Approved
0.6902 Remote Similarity NPD6777 Approved
0.6902 Remote Similarity NPD6776 Approved
0.6902 Remote Similarity NPD6779 Approved
0.6901 Remote Similarity NPD2629 Approved
0.6894 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6885 Remote Similarity NPD7700 Phase 2
0.6885 Remote Similarity NPD7699 Phase 2
0.6875 Remote Similarity NPD8313 Approved
0.6875 Remote Similarity NPD8312 Approved
0.6871 Remote Similarity NPD1535 Discovery
0.6863 Remote Similarity NPD6663 Approved
0.6855 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6855 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6855 Remote Similarity NPD4110 Phase 3
0.6846 Remote Similarity NPD3225 Approved
0.6845 Remote Similarity NPD8319 Approved
0.6845 Remote Similarity NPD3749 Approved
0.6845 Remote Similarity NPD8320 Phase 1
0.6832 Remote Similarity NPD4357 Discontinued
0.6829 Remote Similarity NPD3226 Approved
0.6826 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6824 Remote Similarity NPD1481 Phase 2
0.6821 Remote Similarity NPD5736 Approved
0.6818 Remote Similarity NPD1240 Approved
0.6815 Remote Similarity NPD5408 Approved
0.6815 Remote Similarity NPD5405 Approved
0.6815 Remote Similarity NPD5404 Approved
0.6815 Remote Similarity NPD2796 Approved
0.6815 Remote Similarity NPD5406 Approved
0.6813 Remote Similarity NPD3887 Approved
0.6813 Remote Similarity NPD2354 Approved
0.6805 Remote Similarity NPD919 Approved
0.6802 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6795 Remote Similarity NPD7097 Phase 1
0.679 Remote Similarity NPD3146 Approved
0.679 Remote Similarity NPD3688 Clinical (unspecified phase)
0.679 Remote Similarity NPD2532 Approved
0.679 Remote Similarity NPD2534 Approved
0.679 Remote Similarity NPD2533 Approved
0.6786 Remote Similarity NPD7768 Phase 2
0.6774 Remote Similarity NPD555 Phase 2
0.6772 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6754 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6754 Remote Similarity NPD7874 Approved
0.6752 Remote Similarity NPD1509 Clinical (unspecified phase)
0.675 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6748 Remote Similarity NPD6273 Approved
0.6744 Remote Similarity NPD3926 Phase 2
0.6742 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6736 Remote Similarity NPD4198 Discontinued
0.6735 Remote Similarity NPD17 Approved
0.6731 Remote Similarity NPD6653 Approved
0.6731 Remote Similarity NPD1607 Approved
0.673 Remote Similarity NPD5958 Discontinued
0.673 Remote Similarity NPD4534 Discontinued
0.6727 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6727 Remote Similarity NPD7458 Discontinued
0.6725 Remote Similarity NPD6959 Discontinued
0.6725 Remote Similarity NPD1247 Approved
0.6712 Remote Similarity NPD1894 Discontinued
0.6711 Remote Similarity NPD2861 Phase 2
0.6709 Remote Similarity NPD2438 Suspended
0.6702 Remote Similarity NPD7698 Approved
0.6702 Remote Similarity NPD7697 Approved
0.6702 Remote Similarity NPD7696 Phase 3
0.669 Remote Similarity NPD9493 Approved
0.669 Remote Similarity NPD228 Approved
0.6689 Remote Similarity NPD1470 Approved
0.6689 Remote Similarity NPD1203 Approved
0.6689 Remote Similarity NPD2797 Approved
0.6688 Remote Similarity NPD3268 Approved
0.6687 Remote Similarity NPD1652 Phase 2
0.6686 Remote Similarity NPD7229 Phase 3
0.6685 Remote Similarity NPD8360 Approved
0.6685 Remote Similarity NPD8361 Approved
0.6667 Remote Similarity NPD2982 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data